AI-generated summary
The authors report a systematic review and meta-analysis of randomized trials of botulinum toxin type A for painful temporomandibular disorders. BTX-A was slightly more effective than placebo for pain at one month, with no significant differences at three and six months, and was not associated with a significant increase in adverse events. The authors state the evidence is of low quality and insufficient to support its use.
- Studies included
- 12
- Who or what was studied
- People with painful temporomandibular disorders enrolled in randomized controlled trials
- Limits stated in the abstract
- The authors state the quality of the evidence was low and that high-quality randomized trials are needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Systematic review, Meta-analysis, Laser, Low-level laser therapy, Confidence interval. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.